Opioid Drug News and Research

RSS
Opioid epidemic likely applies to high-risk dialysis population, study shows

Opioid epidemic likely applies to high-risk dialysis population, study shows

FDA approves drug as add-on treatment for Parkinson's disease patients

FDA approves drug as add-on treatment for Parkinson's disease patients

Study finds sharp rise in number of older Americans taking multiple brain-affecting drugs

Study finds sharp rise in number of older Americans taking multiple brain-affecting drugs

New vaccine shows potential to decrease risk of fatal opioid overdose

New vaccine shows potential to decrease risk of fatal opioid overdose

New initiative aims to prevent opioid addition among surgical patients in Michigan

New initiative aims to prevent opioid addition among surgical patients in Michigan

Majority of American adults use prescription drugs inappropriately and dangerously

Majority of American adults use prescription drugs inappropriately and dangerously

FDA issues draft guidance to support development of approved ADF opioids

FDA issues draft guidance to support development of approved ADF opioids

Opioid abuse in pregnant women increases 127% in 14 years

Opioid abuse in pregnant women increases 127% in 14 years

New lifesaving product aims at reducing death toll from heroin abuse

New lifesaving product aims at reducing death toll from heroin abuse

New tool promises to reduce deaths caused by heroin overdose

New tool promises to reduce deaths caused by heroin overdose

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Treatment for opioid overdose now available for use by non-medical personnel

Treatment for opioid overdose now available for use by non-medical personnel

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Researchers develop new opioid drug for chronic pain

Researchers develop new opioid drug for chronic pain

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

FDA approves Amneal’s generic Suboxone to treat opioid drug dependence

FDA approves Amneal’s generic Suboxone to treat opioid drug dependence

HIV transmission can be reduced by using opioid substitution treatments instead of injection drug use

HIV transmission can be reduced by using opioid substitution treatments instead of injection drug use

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Four steps to help curb military suicide

Four steps to help curb military suicide